<DOC>
	<DOC>NCT02651714</DOC>
	<brief_summary>This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with treatment-resistant pruritus diagnosed with atopic dermatitis.</brief_summary>
	<brief_title>Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pruritus</mesh_term>
	<criteria>Male and nonpregnant, nonlactating female subjects aged 18 65 years (inclusive); Diagnosed with atopic dermatitis Suffering from chronic pruritus with pruritus being actively present Chronic pruritus due to condition other than atopic dermatitis (AD) Participation in a previous tradipitant (LY686017 or VLY686) trial; Anyone affiliated with the site or sponsor and/or anyone who may consent under duress; Any other sound medical reason as determined by the Investigator including any condition which may lead to an unfavorable riskbenefit of study participation, may interfere with study compliance or may confound study results.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>